Adcetris FDA approval expanded to include later-stage Hodgkin's
(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency said Tuesday in a news ...
Mar 21, 2018
0
4